Literature DB >> 23243076

Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Maria A Nagel1, Igor Traktinskiy, Kurt R Stenmark, Maria G Frid, Alexander Choe, Don Gilden.   

Abstract

OBJECTIVE: Pathologic changes in varicella-zoster virus (VZV)-infected arteries include inflammation, thickened intima, and paucity of smooth muscle cells. Since no criteria have been established for early vs late VZV vasculopathy, we examined inflammatory cells and their distribution in 6 normal arteries, and 2 VZV-infected arteries 3 days after onset of disease (early) and 10 months after protracted neurologic disease (late).
METHODS: VZV-infected temporal artery obtained 3 days after onset of ischemic optic neuropathy from an 80-year-old man, VZV-infected middle cerebral artery (MCA) obtained 10 months after protracted disease from a 73-year-old man, and 5 MCAs and 1 temporal artery from normal subjects, age 22-60 years, were examined histologically and immunohistochemically using antibodies against VZV and inflammatory cell subsets.
RESULTS: In both early and late VZV vasculopathy, T cells, activated macrophages, and rare B cells were found in adventitia and intima. In adventitia of early VZV vasculopathy, neutrophils and VZV antigen were abundant and a thickened intima was associated with inflammatory cells in vaso vasorum vessels. In media of late VZV vasculopathy, viral antigen, but not leukocytes, was found. VZV was not seen in inflammatory cells. Inflammatory cells were absent in control arteries.
CONCLUSIONS: Both VZV and neutrophils exclusively in adventitia in early VZV vasculopathy indicate that disease begins there. Late VZV vasculopathy is distinguished by viral antigen without inflammation in media, revealing a human virus in an immunoprivileged arterial media. Association of thickened intima and inflammation in vaso vasorum vessels in early VZV vasculopathy support the role of virus-induced inflammation in vessel wall remodeling.

Entities:  

Mesh:

Year:  2012        PMID: 23243076      PMCID: PMC3589199          DOI: 10.1212/WNL.0b013e31827b1ab9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

Review 1.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

2.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

Authors:  Maria G Frid; Jacqueline A Brunetti; Danielle L Burke; Todd C Carpenter; Neil J Davie; John T Reeves; Mark T Roedersheimer; Nico van Rooijen; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury.

Authors:  G Ferry; M Lonchampt; L Pennel; G de Nanteuil; E Canet; G C Tucker
Journal:  FEBS Lett       Date:  1997-02-03       Impact factor: 4.124

4.  Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.

Authors:  Richard Salazar; Andrew N Russman; Maria A Nagel; Randall J Cohrs; Ravi Mahalingam; D Scott Schmid; Bette K Kleinschmidt-DeMasters; Eve M VanEgmond; Don Gilden
Journal:  Arch Neurol       Date:  2011-04

5.  Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited.

Authors:  D H Gilden; B K Kleinschmidt-DeMasters; M Wellish; E T Hedley-Whyte; B Rentier; R Mahalingam
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

6.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-1995. A 73-year-old man with focal brain lesions and peripheral-nerve disease.

Authors: 
Journal:  N Engl J Med       Date:  1995-02-16       Impact factor: 91.245

7.  Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension.

Authors:  F Perros; P Dorfmüller; R Souza; I Durand-Gasselin; V Godot; F Capel; S Adnot; S Eddahibi; M Mazmanian; E Fadel; P Hervé; G Simonneau; D Emilie; M Humbert
Journal:  Eur Respir J       Date:  2006-12-20       Impact factor: 16.671

8.  Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency.

Authors:  S Debrus; C Sadzot-Delvaux; A F Nikkels; J Piette; B Rentier
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  VZV vasculopathy associated with myelo-radiculoganglio-meningo-encephalitis: an autopsy case of an immunocompetent 66-year-old male.

Authors:  Yu Miyazaki; Yuichi Riku; Yoji Goto; Kazuo Mano; Mari Yoshida; Yoshio Hashizume
Journal:  J Neurol Sci       Date:  2008-08-30       Impact factor: 3.181

10.  Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.

Authors:  Y Itoh; H Nagase
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

View more
  38 in total

Review 1.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  Varicella-Zoster Virus Downregulates Programmed Death Ligand 1 and Major Histocompatibility Complex Class I in Human Brain Vascular Adventitial Fibroblasts, Perineurial Cells, and Lung Fibroblasts.

Authors:  Dallas Jones; Anna Blackmon; C Preston Neff; Brent E Palmer; Don Gilden; Hussain Badani; Maria A Nagel
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Editorial commentary: varicella zoster virus infection: generally benign in kids, bad in grown-ups.

Authors:  Maria Nagel; Don Gilden
Journal:  Clin Infect Dis       Date:  2014-04-02       Impact factor: 9.079

4.  Varicella Zoster Virus and Giant Cell Arteritis.

Authors:  Anne A Gershon; Michael Gershon
Journal:  J Infect Dis       Date:  2016-03-31       Impact factor: 5.226

Review 5.  Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis.

Authors:  Maria A Nagel; Dallas Jones; Ann Wyborny
Journal:  J Neuroimmunol       Date:  2017-03-18       Impact factor: 3.478

Review 6.  Neurological complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

7.  Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries.

Authors:  Maria A Nagel; Alexander Choe; Nelly Khmeleva; Lindsey Overton; April Rempel; Ann Wyborny; Igor Traktinskiy; Don Gilden
Journal:  J Neurovirol       Date:  2013-03-01       Impact factor: 2.643

8.  Hemorrhagic and ischemic stroke secondary to herpes simplex virus type 2 meningitis and vasculopathy.

Authors:  Samuel B Snider; Claire S Jacobs; Patricia S Scripko; Joshua P Klein; Jennifer L Lyons
Journal:  J Neurovirol       Date:  2014-05-08       Impact factor: 2.643

9.  Varicella Zoster Virus Alters Expression of Cell Adhesion Proteins in Human Perineurial Cells via Interleukin 6.

Authors:  Anna M Blackmon; Christina N Como; Andrew N Bubak; Teresa Mescher; Dallas Jones; Maria A Nagel
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

10.  Elevated serum substance P during simian varicella virus infection in rhesus macaques: implications for chronic inflammation and adverse cerebrovascular events.

Authors:  Andrew N Bubak; Vicki Traina-Dorge; Christina N Como; Brittany Feia; Catherine M Pearce; Laura Doyle-Meyers; Arpita Das; Jayme Looper; Ravi Mahalingam; Maria A Nagel
Journal:  J Neurovirol       Date:  2020-09-22       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.